CDXS insider purchase: 50,000 shares; beneficial ownership 727,053
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Codexis, Inc. (CDXS) reported an insider open‑market purchase. Director Stephen G. Dilly bought 50,000 shares of common stock on 11/11/2025 at a weighted average price of $1.8473, executed in multiple trades ranging from $1.7550 to $1.90.
After this transaction, he beneficially owns 727,053 shares, held directly. This total includes 2,000 shares acquired under the Employee Stock Purchase Plan on May 10, 2025 and 2,000 shares acquired on Nov 10, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
DILLY STEPHEN GEORGE
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 50,000 | $1.8473 | $92K |
Holdings After Transaction:
Common Stock — 727,053 shares (Direct)
Footnotes (1)
- This transaction was executed in multiple trades in prices ranging from $1.7550 to $1.90, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. Includes 2,000 shares acquired under the issuer's Employee Stock Purchase Plan on May 10, 2025. Includes 2,000 shares acquired under the issuer's Employee Stock Purchase Plan on November 10, 2025.
FAQ
What did Codexis (CDXS) disclose in this Form 4?
Director Stephen G. Dilly purchased 50,000 CDXS shares on 11/11/2025 at a weighted average of $1.8473.
Were the trades executed in a single transaction?
No. The filing states multiple trades within the $1.7550–$1.90 range; the price shown is a weighted average.
Does beneficial ownership include recent ESPP purchases?
Yes. It includes 2,000 shares acquired on May 10, 2025 and 2,000 on Nov 10, 2025 under the ESPP.
Were any derivative securities reported in this filing?
No derivative securities are listed in the provided excerpt of the filing.